Categories AlphaGraphs, Cannabis, Earnings

Canopy Growth Corporation (CGC) Q4 Earnings: Key financials and quarterly highlights

Canopy Growth Corporation (NYSE: CGC) reported fourth-quarter 2021 earnings results today.

Net revenues increased 38% year-over-year to CAD $148 million.

Net loss attributable to Canopy Growth Corporation was CAD $699 million, or CAD $1.85 per share, versus a net loss of CAD $1.3 billion, or CAD $3.72 per share, last year.

  • Canopy Growth reports Q2 2021 earnings results
  • Canopy Growth (CGC) Q1 2021 Earnings AlphaGraph

Most Popular

Context Therapeutics: Another clinical-stage oncology research firm to go public soon

The US primary markets seem to be having a record-breaking start to the year, with over $171 billion raised in the first half of 2021 compared to $168 billion for

Biogen (BIIB) Stock: Does FDA nod for Aduhelm offer a buying opportunity?

The pharmaceutical industry has been witnessing hectic activity for some time, with most drug makers either channelizing their resources for vaccine development or engaging in COVID care programs. Biotechnology giant

IPO News: Monte Rosa Therapeutics will go public this week, here are a few things to know

Biotechnology company Monte Rosa Therapeutics is slated to go public this week. In a pandemic-ridden world, this industry is expanding at a healthy pace. The global biotechnology market is estimated

Add Comment
Loading...
Cancel
Viewing Highlight
Loading...
Highlight
Close
Top